Bundamedik Tbk PT (BMHS) — Cash Flow Reinvestment Rate
Bundamedik Tbk PT (BMHS) has a Cash Flow Reinvestment Rate of 0.58x as of December 2025, reinvesting Rp116.26 Billion (capex Rp116.26 Billion ) from operating cash flow of Rp199.64 Billion. See Bundamedik Tbk PT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bundamedik Tbk PT Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Bundamedik Tbk PT across 8 annual periods. For the full cash flow conversion analysis, see Bundamedik Tbk PT cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Bundamedik Tbk PT (2018–2025)
Year-by-year capital reinvestment analysis for Bundamedik Tbk PT. See Bundamedik Tbk PT (BMHS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (IDR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.87x | Rp218.91 Billion | Rp250.62 Billion | Rp218.91 Billion | ▼ -93.8% |
| 2024 | 14.16x | Rp481.32 Billion | Rp33.98 Billion | Rp236.03 Billion | ▲ +72.8% |
| 2023 | 8.20x | Rp421.57 Billion | Rp51.44 Billion | Rp209.35 Billion | ▲ +163.1% |
| 2022 | 3.12x | Rp739.76 Billion | Rp237.47 Billion | Rp301.73 Billion | ▲ +336.2% |
| 2021 | 0.71x | Rp249.57 Billion | Rp349.44 Billion | Rp228.08 Billion | ▲ +91.2% |
| 2020 | 0.37x | Rp71.10 Billion | Rp190.36 Billion | Rp49.61 Billion | ▼ -60.2% |
| 2019 | 0.94x | Rp84.26 Billion | Rp89.72 Billion | Rp72.50 Billion | ▼ -73.7% |
| 2018 | 3.57x | Rp156.54 Billion | Rp43.79 Billion | Rp156.54 Billion | — |